脑脊液α-突触核蛋白寡聚体与神经丝轻链可区分多系统萎缩与路易体突触核蛋白病
本研究探索脑脊液α-突触核蛋白寡聚体和神经丝轻链作为早期多系统萎缩(MSA)标志物的价值。在发现队列(早期MSA 24例,健康对照14例)和确认队列(早期MSA 38例,帕金森病16例,路易体痴呆13例,对照15例)中,神经丝轻链可完美区分MSA与对照,αSyn-PMCA在MSA中阳性且反应动力学与路易体突触核蛋白病明显不同,可完美区分。结论认为这两种标志物有助于早期MSA的诊断与鉴别。
要点
- 脑脊液神经丝轻链在早期MSA中显著升高,可完美区分MSA与健康对照。
- αSyn-PMCA在MSA中阳性,在对照中阴性,且反应动力学可区分MSA与路易体病。
- 神经丝轻链在帕金森病和路易体痴呆中显著低于MSA。
核心结论
- 脑脊液神经丝轻链和α-突触核蛋白寡聚体可可靠区分早期多系统萎缩与健康对照及路易体突触核蛋白病。
研究设计与样本
- 发现队列:早期MSA患者24例和匹配健康对照14例,用ELISA测神经丝轻链、PMCA检测αSyn寡聚体。
- 确认队列:前瞻性入组早期MSA 38例、帕金森病16例、路易体痴呆13例和对照15例。
主要发现
- 发现队列中神经丝轻链在MSA患者中显著升高,与对照完美分离。
- 发现队列中αSyn-PMCA在所有对照中无反应,所有MSA样本阳性。
- 确认队列中神经丝轻链再次完美区分MSA与对照,且帕金森病和路易体痴呆显著低于MSA。
- 确认队列中PMCA在所有对照中无反应,除2例MSA外所有MSA阳性。
- 所有帕金森病和除2例外的路易体痴呆样本αSyn聚集阳性,但反应动力学与MSA明显不同,可完美区分。
临床怎么用
- 脑脊液神经丝轻链和αSyn-PMCA可作为早期MSA的诊断生物标志物,并用于与路易体突触核蛋白病鉴别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the role of alpha-synuclein (αSyn) oligomers and neurofilament light chain (NFL) in cerebrospinal fluid (CSF) as markers of early multiple system atrophy (MSA) and to contrast findings with Lewy body synucleinopathies. METHODS: In a discovery cohort of well-characterized early MSA patients (n = 24) and matched healthy controls (CON, n = 14), we utilized enzyme-linked immunosorbent assay to measure NFL and protein misfolding cyclic amplification (PMCA) to detect αSyn oligomers in CSF. We confirmed findings in a separate prospectively enrolled cohort of patients with early MSA (n = 38), Parkinson disease (PD, n = 16), and dementia with Lewy bodies (DLB, n = 13), and CON subjects (n = 15). RESULTS: In the discovery cohort, NFL was markedly elevated in MSA patients, with perfect separation from CON. αSyn-PMCA was nonreactive in all CON, whereas all MSA samples were positive. In the confirmatory cohort, NFL again perfectly separated MSA from CON, and was significantly lower in PD and DLB compared to MSA. PMCA was again nonreactive in all CON, and positive in all but 2 MSA cases. All PD and all but 2 DLB samples were also positive for αSyn aggregates but with markedly different reaction kinetics from MSA; aggregation occurred later, but maximum fluorescence was higher, allowing for perfect separation of reactive samples between MSA and Lewy body synucleinopathies. INTERPRETATION: NFL and αSyn oligomers in CSF faithfully differentiate early MSA not only from CON but also from Lewy body synucleinopathies. The findings support the role of these markers as diagnostic biomarkers, and have important implications for understanding pathophysiologic mechanisms underlying the synucleinopathies. ANN NEUROL 2020;88:503-512.
引用
- Singer W, Schmeichel AM, Shahnawaz M, et al. Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies. Ann Neurol. 2020. PMID: 32557811. doi:10.1002/ana.25824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。